Jerusalem Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Jerusalem Pharmaceuticals has a total shareholder equity of $64.4M and total debt of $1.9M, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are $83.4M and $19.0M respectively. Jerusalem Pharmaceuticals's EBIT is $10.3M making its interest coverage ratio 415.8. It has cash and short-term investments of $13.8M.
Key information
3.0%
Debt to equity ratio
US$1.91m
Debt
Interest coverage ratio | 415.8x |
Cash | US$13.83m |
Equity | US$64.40m |
Total liabilities | US$19.04m |
Total assets | US$83.44m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: JPH's short term assets ($53.2M) exceed its short term liabilities ($14.2M).
Long Term Liabilities: JPH's short term assets ($53.2M) exceed its long term liabilities ($4.9M).
Debt to Equity History and Analysis
Debt Level: JPH has more cash than its total debt.
Reducing Debt: JPH's debt to equity ratio has reduced from 3.3% to 3% over the past 5 years.
Debt Coverage: JPH's debt is well covered by operating cash flow (912.4%).
Interest Coverage: JPH's interest payments on its debt are well covered by EBIT (415.8x coverage).